Micronization at its Finest
For over 30 years, Microsize has been a pioneer in enhancing dissolution and bioavailability of Active Pharmaceutical Ingredients (APIs) via particle size reduction using micronization technologies.
Largest US Micronization Footprint
Years of Experience
Years of Successful FDA Inspections
Countless – Satisfied Customers
Operating from a 100,000 square foot, US-based, state-of-the-art, FDA inspected facility, Microsize has the experience and capabilities to rapidly develop, scale up, and process APIs and excipients ranging from grams to multi-metric tons, including highly potent compounds.
Think Big. Think Microsize!